Showing results (1-10 of 364) with videos related to
Sort By:
Pageof 37
Current Opinion in Oncology|April 1, 1992
Modern trends in bone marrow transplantation for acute myeloid and acute lymphoblastic leukemiaR Chopra, A H GoldstoneCurrent Opinion in Hematology|July 1, 1994
Recent advances in Hodgkin's diseaseR Chopra, A H GoldstoneLeukemia & Lymphoma|January 1, 1992
Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centreR Chopra, A Fielding, A H GoldstoneBritish Journal of Haematology|April 1, 1994
Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patientsW Mills, R Chopra, D C Linch, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1991
Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patientsR Chopra, S Blair, J Strang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphomaW Mills, R Chopra, A McMillan, et al.Bone Marrow Transplantation|February 1, 1994
Detection and significance of pulmonary Hodgkin's disease at autologous bone marrow transplantationD J Grimwade, R Chopra, A King, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry dataR Chopra, A H Goldstone, R Pearce, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
The case for and against high-dose therapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remissionA H GoldstoneBlood|March 1, 1993
The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patientsR Chopra, A K McMillan, D C Linch, et al.Pageof 37